Hainan Yew Pharmaceutical

Hainan Yew Pharmaceutical is a Chinese pharmaceutical manufacturer focused on taxane-based oncology products and related small-molecule pharmaceutical manufacturing. The company was established in 2009 in Haikou, Hainan, and operates as a subsidiary of Fujian Sansan Pharmaceutical-related ownership entities. Public company-profile sources describe the business as integrating research and development, production, and sales, with GMP-compliant manufacturing facilities. Its disclosed product focus includes paclitaxel extraction/purification, docetaxel synthesis, paclitaxel injection, and docetaxel injection, indicating a commercial-stage business centered on anti-cancer injectable products and APIs. Available evidence suggests it is primarily a manufacturing and commercial pharmaceutical company rather than an innovation-stage biotech platform company.